Paper30622011
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
Burmaoglu S and 5 others. Bioorg Chem, 2019. Cited by 97 papers, by iCite.
Cite this record
ConductScience Library. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors. Papers, record 30622011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30622011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbonic Anhydrase Inhibitors | Major topic |
| Chalcones | Major topic |
| Cholinesterase Inhibitors | Major topic |
| Glycoside Hydrolase Inhibitors | Major topic |
| Acetylcholinesterase | |
| Butyrylcholinesterase | |
| Carbonic Anhydrase I | |
| Carbonic Anhydrase II | |
| Humans | |
| Molecular Structure | |
| Carrier Proteins | |
| Nerve Tissue Proteins |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42133206 | Integrated computational modeling of chalcone-based inhibitors targeting carbonic anhydrase I and II: 3D-QSAR, molecular docking, and dynamics simulations. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42133206 | PubMed |
| 41726615 | Activity-Selectivity of Flavonoid Derivatives in Endometriotic Cells. | ACS Omega | 2026 | https://conductscience.org/library/papers/41726615 | PubMed |
| 40232392 | Antioxidants: a comprehensive review. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/40232392 | PubMed |
| 40126739 | Innovative approaches in acetylcholinesterase inhibition: a pathway to effective Alzheimer's disease treatment. | Mol Divers | 2025 | https://conductscience.org/library/papers/40126739 | PubMed |
| 38283214 | Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies. | RSC Med Chem | 2024 | https://conductscience.org/library/papers/38283214 | PubMed |
| 38170420 | Organohalogen chalcones: design, synthesis, ADMET prediction, molecular dynamics study and inhibition effect on acetylcholinesterase and carbonic anhydrase. | Mol Divers | 2024 | https://conductscience.org/library/papers/38170420 | PubMed |
| 37396160 | Antihyperglycemic and anti-type 2 diabetic activity of marine hydroquinone isolated from brown algae (Dictyopteris polypodioides). | J Tradit Complement Med | 2023 | https://conductscience.org/library/papers/37396160 | PubMed |
| 37190818 | A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors. | CNS Neurol Disord Drug Targets | 2024 | https://conductscience.org/library/papers/37190818 | PubMed |
| 37110646 | Naturally Occurring Chalcones with Aggregation-Induced Emission Enhancement Characteristics. | Molecules | 2023 | https://conductscience.org/library/papers/37110646 | PubMed |
| 36986640 | Synthesis of Schiff Bases Containing Phenol Rings and Investigation of Their Antioxidant Capacity, Anticholinesterase, Butyrylcholinesterase, and Carbonic Anhydrase Inhibition Properties. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986640 | PubMed |
| 36838726 | Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects. | Molecules | 2023 | https://conductscience.org/library/papers/36838726 | PubMed |
| 36655459 | Experimental Approaches to Diabetes Mellitus. | Eurasian J Med | 2022 | https://conductscience.org/library/papers/36655459 | PubMed |
| 36561337 | Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36561337 | PubMed |
| 36508118 | Acetylphenyl-substituted imidazolium salts: synthesis, characterization, in silico studies and inhibitory properties against some metabolic enzymes. | Mol Divers | 2023 | https://conductscience.org/library/papers/36508118 | PubMed |
| 36364255 | Synthesis of Novel Bromophenol with Diaryl Methanes-Determination of Their Inhibition Effects on Carbonic Anhydrase and Acetylcholinesterase. | Molecules | 2022 | https://conductscience.org/library/papers/36364255 | PubMed |
| 36296499 | Sahlep (Dactylorhiza osmanica): Phytochemical Analyses by LC-HRMS, Molecular Docking, Antioxidant Activity, and Enzyme Inhibition Profiles. | Molecules | 2022 | https://conductscience.org/library/papers/36296499 | PubMed |
| 36185151 | The palladium-based complexes bearing 1,3-dibenzylbenzimidazolium with morpholine, triphenylphosphine, and pyridine derivate ligands: synthesis, characterization, structure and enzyme inhibitions. | Heliyon | 2022 | https://conductscience.org/library/papers/36185151 | PubMed |
| 36105949 | Heterocyclic compounds as a magic bullet for diabetes mellitus: a review. | RSC Adv | 2022 | https://conductscience.org/library/papers/36105949 | PubMed |
| 35630658 | Chalcone Scaffolds Exhibiting Acetylcholinesterase Enzyme Inhibition: Mechanistic and Computational Investigations. | Molecules | 2022 | https://conductscience.org/library/papers/35630658 | PubMed |
| 35328542 | Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328542 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 | NCBI Gene |
| BCHE | 590 | PubTator's text mining | https://conductscience.org/library/genes/590 | NCBI Gene |
| CA1 | 759 | PubTator's text mining | https://conductscience.org/library/genes/759 | NCBI Gene |
| CA2 | 760 | PubTator's text mining | https://conductscience.org/library/genes/760 | NCBI Gene |
| CYP24A1 | 1591 | PubTator's text mining | https://conductscience.org/library/genes/1591 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30622011
GET https://conductscience.org/api/papers/v1/30622011/cited_by?page=2